Asia Pacific Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

The embolotherapy market in Asia Pacific is expected to grow from US$ 781.80 million in 2022 to US$ 1,272.58 million by 2028. It is estimated to grow at a CAGR of 8.5% from 2022 to 2028.

Growing Use of Liquid Embolic Agents to Fuel Embolotherapy Market in Asia Pacific during 2022–2028

Liquid embolic agents are gaining attention owing to their advantages in distal infiltration where solid embolic agents cannot reach, enabling extensive embolization. Liquid formulations have a well-established role in the therapeutic embolization of blood vessels with the widespread use of cyanoacrylate glues, precipitating polymer suspensions, sclerosing agents, and viscous emulsions of oil and chemotherapeutic agents—the emerging market for next-generation liquid embolic aims to address a few shortcomings of the currently used products. There are currently two main liquid agents used for embolization procedures in the clinics—ethylene-vinyl alcohol (EVA) copolymer solution (such as Onyx and Medtronic) and iodinated poppy seed oil (such as Lipiodol and Guerbet). Lipiodol has been used for many years as an imaging agent and is used off-label in the treatment of hepatocellular carcinoma (HCC), where it is mixed with aqueous chemotherapy solutions to create a viscous emulsion that aids in temporarily reducing blood flow. Prominent players are constantly focusing on maintaining their leadership position in the market by continuously introducing new products and improving the existing products to broaden the use of embolotherapy techniques. For instance, in July 2021, Terumo Medical Corporation announced the launch of its AZUR Vascular Plug. The company claims that the plug is compatible with a microcatheter to occlude arteries up to 8mm in diameter. The newest addition to Terumo's robust embolization portfolio is indicated for use to reduce or block the rate of blood flow in arteries of the peripheral vasculature. In March 2022, Guerbet announced that it would double its line of microcatheters and launch a new line of guidewires to offer a broad range of interventional imaging and embolization solutions. SeQure by Guerbet is the reflux control microcatheter enabling a fluid barrier technology for flow-directed embolization. The new model is designed to deliver targeted treatment and use a wider range of beads blocks, from extra-small to large. Therefore, the use of liquid embolic is likely to introduce new trends in the embolotherapy market.

Market Overview

The Asia Pacific embolotherapy market is segmented into China, Japan, India, Australia, South Korea, and the rest of Asia Pacific. The growth of the market in Asia Pacific is attributed to factors such as the rising prevalence of brain stroke, coronary artery diseases, and heart diseases; increasing surgical procedures; growing number of hospitals and ambulatory surgeries centers; focus by industry players in Japan; and developing healthcare infrastructure in India. China faces a high burden of cardiovascular diseases due to smoking and unhealthy diet. As per the World Heart Federation, 87% of total adult deaths in China are recorded due to noncommunicable diseases, including CVDs. The incidence of stroke and abdominal aortic aneurysms has increased in the past years, which is driving the adoption of embolotherapy. According to the Global Burden of Disease Study 2019, there were 3.94 million new stroke cases, 28.76 million prevalent cases, and 2.19 million deaths due to stroke in China.

Asia Pacific Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

Asia Pacific Embolotherapy Market Segmentation

The Asia Pacific embolotherapy market is segmented into product, disease indication, procedure, end user, and country.
Based on product, the market is segmented into embolic agents and support devices. The embolic agents segment registered the largest market share in 2022. Based on disease indication, the market is categorized into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others. The cancer segment held the largest market share in 2022. Based on procedure, the Asia Pacific embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment held the largest market share in 2022. Based on end user, the Asia Pacific embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2022. Based on country, the market is segmented into China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. China dominated the market share in 2022. Abbott Laboratories; Boston Scientific Corporation; Cook Medical LLC; Johnson & Johnson; Medtronic; Acandis GmbH; Balt USA LLC; Stryker Corporation; Guerbet LLC; and Terumo Corporation are the leading companies operating in the embolotherapy market in the region.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Embolotherapy Market – by Product

1.3.2 Asia Pacific Embolotherapy Market – by Disease Indication

1.3.3 Asia Pacific Embolotherapy Market – by Procedure

1.3.4 Asia Pacific Embolotherapy Market – by End User

1.3.5 Asia Pacific Embolotherapy Market– By Country

2. Asia Pacific Embolotherapy Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Embolotherapy Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinion

5. Asia Pacific Embolotherapy Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Boosting Patient Preference for Minimally Invasive Procedures

5.1.2 Surging Incidence of Hypertension, Obesity, Smoking, and Alcoholism

5.2 Market Restraints

5.2.1 Accessibility of Other Alternative Therapies

5.3 Market Opportunity

5.3.1 Widening Applications of Embolotherapy

5.4 Market Trend

5.4.1 Growing Use of Liquid Embolic Agents

5.5 Impact analysis

6. Asia Pacific Embolotherapy Market Analysis

6.1 Asia Pacific Embolotherapy Market Revenue Forecast and Analysis

7. Asia Pacific Embolotherapy Market – by Product

7.1 Overview

7.2 Asia Pacific Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

7.3 Embolic Agents

7.3.1 Overview

7.3.2 Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.3 Microspheres

7.3.3.1 Overview

7.3.3.2 Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.4 Embolic Coils

7.3.4.1 Overview

7.3.4.2 Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.5 Embolic Plug Systems

7.3.5.1 Overview

7.3.5.2 Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.6 Detachable Balloons

7.3.6.1 Overview

7.3.6.2 Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.7 Liquid Embolic Agents

7.3.7.1 Overview

7.3.7.2 Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.8 Others

7.3.8.1 Overview

7.3.8.2 Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4 Support Devices

7.4.1 Overview

7.4.2 Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.3 Microcatheters

7.4.3.1 Overview

7.4.3.2 Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.4 Guidewires

7.4.4.1 Overview

7.4.4.2 Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Embolotherapy Market Analysis – by Disease Indication

8.1 Overview

8.2 Asia Pacific Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

8.3 Cancer

8.3.1 Overview

8.3.2 Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1 Liver Cancer

8.3.2.1.1 Overview

8.3.2.1.2 Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2 Kidney Cancer

8.3.2.2.1 Overview

8.3.2.2.2 Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.3 Other Cancers

8.3.2.3.1 Overview

8.3.2.3.2 Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Peripheral Vascular Diseases

8.4.1 Overview

8.4.2 Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurological Diseases

8.5.1 Overview

8.5.2 Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Urological and Nephrological Disorders

8.6.1 Overview

8.6.2 Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Gastrointestinal Disorders

8.7.1 Overview

8.7.2 Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Embolotherapy Market Analysis – by Procedure

9.1 Overview

9.2 Asia Pacific Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

9.3 Transcatheter Arterial Embolization (TAE)

9.3.1 Overview

9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)

9.4.1 Overview

9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Transarterial Chemoembolization (TACE)

9.5.1 Overview

9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Embolotherapy Market Analysis – By End User

10.1 Overview

10.2 Asia Pacific Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Ambulatory Surgical Centers

10.4.1 Overview

10.4.2 Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Other End Users

10.5.1 Overview

10.5.2 Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11. Asia Pacific Embolotherapy Market – Country Analysis

11.1 Overview

11.1.1 Asia Pacific: Embolotherapy Market, by Country, 2022 & 2028 (%)

11.1.1.1 China: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.1 Overview

11.1.1.1.2 China: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3 China Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3.1 China Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3.2 China Embolotherapy Market, by Support Device – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.4 China Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.4.1 China Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.5 China Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.6 China Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2 Japan: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.1 Japan: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2 Japan Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2.1 Japan Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2.2 Japan Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3 Japan Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3.1 Japan Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.4 Japan Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.5 Japan Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3 India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.1 Overview

11.1.1.3.2 India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.3 India: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3.1 India: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3.2 India: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.4 India: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.4.1 India: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.5 India: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.6 India: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.4 South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.1 Overview

11.1.1.4.2 South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.3 South Korea: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.3.1 South Korea: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.3.2 South Korea: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.4 South Korea: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.4.1 South Korea: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.5 South Korea: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.6 South Korea: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.5 Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.1 Overview

11.1.1.5.2 Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.3 Australia: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.3.1 Australia: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.3.2 Australia: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.4 Australia: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.4.1 Australia: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.5 Australia: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.6 Australia: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.6 Rest of Asia Pacific: Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.1 Overview

11.1.1.6.2 Rest of Asia Pacific: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.3 Rest of Asia Pacific: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.3.1 Rest of Asia Pacific: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.3.2 Rest of Asia Pacific: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.4 Rest of Asia Pacific: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.4.1 Rest of Asia Pacific: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.5 Rest of Asia Pacific: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.6 Rest of Asia Pacific: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

12. Asia Pacific Embolotherapy Market –Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Boston Scientific Corporation

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Cook Medical LLC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Johnson & Johnson

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Medtronic

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Acandis GmbH

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Balt USA LLC

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Stryker Corporation

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Guerbet LLC

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Terumo Corporation

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. China Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2. China Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 3. China Embolotherapy Market, by Support Device – Revenue and Forecast to 2028 (US$ Million)

Table 4. China Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5. China Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 6. China Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 7. China Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 8. Japan Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 9. Japan Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 10. Japan Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 11. Japan Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 12. Japan Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 13. Japan Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 14. Japan Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 15. India: Embolotherapy Market, By Product – Revenue and Forecast To 2028 (US$ Million)

Table 16. India: Embolotherapy Market, By Embolic Agents – Revenue and Forecast To 2028 (US$ Million)

Table 17. India: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 18. India: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 19. India: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 20. India: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 21. India: Embolotherapy Market, By End User– Revenue and Forecast To 2028 (US$ Million)

Table 22. South Korea: Embolotherapy Market, By Product – Revenue and Forecast To 2028 (US$ Million)

Table 23. South Korea: Embolotherapy Market, By Embolic Agents – Revenue and Forecast To 2028 (US$ Million)

Table 24. South Korea: Embolotherapy Market, By Support Devices – Revenue and Forecast To 2028 (US$ Million)

Table 25. South Korea: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 26. South Korea: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 27. South Korea: Embolotherapy Market, By Procedure – Revenue and Forecast To 2028 (US$ Million)

Table 28. South Korea: Embolotherapy Market, By End User– Revenue and Forecast To 2028 (US$ Million)

Table 29. Australia: Embolotherapy Market, By Product – Revenue and Forecast To 2028 (US$ Million)

Table 30. Australia: Embolotherapy Market, By Embolic Agents – Revenue and Forecast To 2028 (US$ Million)

Table 31. Australia: Embolotherapy Market, By Support Devices – Revenue and Forecast To 2028 (US$ Million)

Table 32. Australia: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 33. Australia: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 34. Australia: Embolotherapy Market, By Procedure – Revenue and Forecast To 2028 (US$ Million)

Table 35. Australia: Embolotherapy Market, By End User– Revenue and Forecast To 2028 (US$ Million)

Table 36. Rest of Asia Pacific: Embolotherapy Market, By Product – Revenue and Forecast To 2028 (US$ Million)

Table 37. Rest of Asia Pacific: Embolotherapy Market, By Embolic Agents – Revenue and Forecast To 2028 (US$ Million)

Table 38. Rest of Asia Pacific: Embolotherapy Market, By Support Devices – Revenue and Forecast To 2028 (US$ Million)

Table 39. Rest of Asia Pacific: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 40. Rest of Asia Pacific: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 41. Rest of Asia Pacific: Embolotherapy Market, By Procedure – Revenue and Forecast To 2028 (US$ Million)

Table 42. Rest Of Asia Pacific: Embolotherapy Market, By End User– Revenue and Forecast To 2028 (US$ Million)

Table 43. Organic Developments Done by Companies

Table 44. Inorganic Developments Done by Companies

Table 45. Glossary of Terms, Asia pacific Embolotherapy Market

LIST OF FIGURES

Figure 1. Asia Pacific Embolotherapy Market Segmentation

Figure 2. Asia Pacific Embolotherapy Market, By Country

Figure 3. Asia Pacific Embolotherapy Market Overview

Figure 4. Embolic Agents Held Largest Share of Product Segment in Asia Pacific Embolotherapy Market

Figure 5. Asia Pacific Embolotherapy Market in China to Show Remarkable Growth During Forecast Period

Figure 6. Asia Pacific Embolotherapy Market, Industry Landscape

Figure 7. Asia Pacific PEST Analysis

Figure 8. Asia Pacific Embolotherapy Market Impact Analysis of Drivers and Restraints

Figure 9. Asia Pacific Embolotherapy Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10. Asia Pacific Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

Figure 11. Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12. Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13. Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14. Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15. Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16. Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17. Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18. Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19. Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20. Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21. Asia Pacific Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

Figure 22. Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Asia Pacific Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

Figure 32. Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Asia Pacific Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

Figure 36. Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. Asia Pacific: Embolotherapy Market, by Key Country – Revenue (2022) (US$ Million)

Figure 40. Asia Pacific: Embolotherapy Market, by Country, 2022 & 2028 (%)

Figure 41. China: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. Japan: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 44. South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 45. Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 46. Rest of Asia Pacific: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific embolotherapy market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific embolotherapy market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the embolotherapy market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000